Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

FDA
News

GlaxoSmithKline Reports Results For Daprodustat Phase 3 Headline Trial: Study Met Primary Efficacy Endpoint, Co. Will Continue Data Analysis In Phase 3 ASCEND Trial

-Reuters

byBenzinga Newsdesk

July 16, 2021

1 minute read

-Reuters

SiriusPoint Announces Daniel S. Loeb Joining Board Of Directors

By Benzinga Newsdesk

Today, 4:49 AM

SIRIUSPOINT ANNOUNCES DANIEL S. LOEB JOINING BOARD OF DIRECTORS Loeb to Focus on Executing Asset Management Strategy and Recruiting Permanent CEO HAMILTON, Bermuda, May 17, 2022 /PRNewswire/ -- SiriusPoint

SPNT

Pfizer Builds Case For COVID-19 Booster As Protection Wanes Over Time

By Vandana Singh

Today, 4:49 AM

Pfizer Inc (NYSE:PFE) said that U.S. regulators should approve a booster dose of the COVID-19 vaccine developed with BioNTech SE (NASDAQ:BNTX)…

BNTX

X Financial Q1 EPS $0.60 Up From $(0.14) YoY, Sales $138.30M Up From $74.52M YoY

By Benzinga Newsdesk

Today, 4:49 AM

X Financial (NYSE: XYF) reported quarterly earnings of $0.60 per share. This is a 528.57 percent increase over losses of $(0.14) per share from the same period last year.

XYF